in
All Tags » Companies » pharmaceuticals (RSS)

Browse by Tags

  • Sign of things to come?

    The big news today is Daiichi Sankyo's acquisition of a controlling stake in Ranbaxy , India's largest pharmaceutical company, for $4.6bn. Analysts have been quick to predict many more such deals which will see international pharma majors entering the generic space. Indian generic players have...
    Posted to ICIS Blogs (Weblog) by Anonymous on 06-12-2008

  • Pharma still keen on M&As

    The Indian pharmaceutical sector is keeping the M&A fire burning with six deals concluded last month, up from eight in the January-March period. The list includes Jubilant Organosys' $255m acquisition of US-based DRAXIS Health and the $218m buyout of Dabur Pharma by Fresenius Kabi . Indian companies...
    Posted to ICIS Blogs (Weblog) by Anonymous on 05-15-2008

  • Matrix mulls Docpharma sale

    Have Indian fine chemical and pharma companies been too hasty in their global acquisitions? I had been hearing talk of some companies running into integration problems or having second thoughts on perceived benefits of their acquisitions. But today’s report that Matrix Labs is exploring sale of Docpharma...
    Posted to ICIS Blogs (Weblog) by Anonymous on 02-29-2008

  • Testing times for CRAMS

    Business is booming in India’s custom research and manufacturing services (CRAMS) industry thanks to the country's strong process chemistry skills, low operational costs and the availability of a skilled workforce. Frost & Sullivan values the Indian CRAMS market at $890m, and expects it to expand...
    Posted to ICIS Blogs (Weblog) by Anonymous on 02-11-2008
Page 1 of 1 (4 items)
© RBI 2008
Powered by Community Server (Commercial Edition), by Telligent Systems